NO934584L - Farmasöytisk granulat - Google Patents

Farmasöytisk granulat

Info

Publication number
NO934584L
NO934584L NO934584A NO934584A NO934584L NO 934584 L NO934584 L NO 934584L NO 934584 A NO934584 A NO 934584A NO 934584 A NO934584 A NO 934584A NO 934584 L NO934584 L NO 934584L
Authority
NO
Norway
Prior art keywords
carrier
mixture
granules
optionally
desogestrel
Prior art date
Application number
NO934584A
Other languages
English (en)
Other versions
NO306928B1 (no
NO934584D0 (no
Inventor
Jan Hendrik Dopper
Cornelis Josephus Maria Va Ven
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27578967&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO934584(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US07/941,026 priority Critical patent/US5395627A/en
Priority to DE69322396T priority patent/DE69322396T2/de
Priority to ES93203476T priority patent/ES2125300T3/es
Priority to DK93203476T priority patent/DK0657161T3/da
Priority to EP93203476A priority patent/EP0657161B1/en
Priority to AT93203476T priority patent/ATE173918T1/de
Priority to NO934584A priority patent/NO306928B1/no
Publication of NO934584D0 publication Critical patent/NO934584D0/no
Priority to FI935584A priority patent/FI111221B/fi
Application filed by Akzo Nv filed Critical Akzo Nv
Priority to CA002111320A priority patent/CA2111320A1/en
Priority to NZ250443A priority patent/NZ250443A/en
Priority to ZA939337A priority patent/ZA939337B/xx
Priority to AU52391/93A priority patent/AU672447B2/en
Priority to JP32229093A priority patent/JP3720385B2/ja
Priority to CN93121510A priority patent/CN1050043C/zh
Priority to US08/366,348 priority patent/US5527543A/en
Publication of NO934584L publication Critical patent/NO934584L/no
Priority to GR990400353T priority patent/GR3029273T3/el
Publication of NO306928B1 publication Critical patent/NO306928B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO934584A 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett NO306928B1 (no)

Priority Applications (16)

Application Number Priority Date Filing Date Title
US07/941,026 US5395627A (en) 1992-09-04 1992-09-04 Pharmaceutical granulate
DE69322396T DE69322396T2 (de) 1992-09-04 1993-12-10 Steroide enthaltende pharmazeutische Granulate
ES93203476T ES2125300T3 (es) 1992-09-04 1993-12-10 Granulados farmaceuticos que contienen esteroides.
DK93203476T DK0657161T3 (da) 1992-09-04 1993-12-10 Farmaceutisk granulat indeholdende steroider
EP93203476A EP0657161B1 (en) 1992-09-04 1993-12-10 Pharmaceutical granulate containing steroids
AT93203476T ATE173918T1 (de) 1992-09-04 1993-12-10 Steroide enthaltende pharmazeutische granulate
NZ250443A NZ250443A (en) 1992-09-04 1993-12-13 Preparation of film coated, steroid-loaded granules
ZA939337A ZA939337B (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
FI935584A FI111221B (fi) 1992-09-04 1993-12-13 Menetelmä farmaseuttisten rakeiden valmistamiseksi
NO934584A NO306928B1 (no) 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett
CA002111320A CA2111320A1 (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
AU52391/93A AU672447B2 (en) 1992-09-04 1993-12-14 Pharmaceutical granulate
JP32229093A JP3720385B2 (ja) 1992-09-04 1993-12-21 医薬顆粒
CN93121510A CN1050043C (zh) 1992-09-04 1993-12-29 药物颗粒
US08/366,348 US5527543A (en) 1992-09-04 1994-12-29 Pharmaceutical granulate
GR990400353T GR3029273T3 (en) 1992-09-04 1999-02-03 Pharmaceutical granulate containing steroids.

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US07/941,026 US5395627A (en) 1992-09-04 1992-09-04 Pharmaceutical granulate
EP93203476A EP0657161B1 (en) 1992-09-04 1993-12-10 Pharmaceutical granulate containing steroids
FI935584A FI111221B (fi) 1992-09-04 1993-12-13 Menetelmä farmaseuttisten rakeiden valmistamiseksi
ZA939337A ZA939337B (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
NZ250443A NZ250443A (en) 1992-09-04 1993-12-13 Preparation of film coated, steroid-loaded granules
NO934584A NO306928B1 (no) 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett
CA002111320A CA2111320A1 (en) 1992-09-04 1993-12-13 Pharmaceutical granulate
AU52391/93A AU672447B2 (en) 1992-09-04 1993-12-14 Pharmaceutical granulate
JP32229093A JP3720385B2 (ja) 1992-09-04 1993-12-21 医薬顆粒
CN93121510A CN1050043C (zh) 1992-09-04 1993-12-29 药物颗粒

Publications (3)

Publication Number Publication Date
NO934584D0 NO934584D0 (no) 1993-12-13
NO934584L true NO934584L (no) 1995-06-14
NO306928B1 NO306928B1 (no) 2000-01-17

Family

ID=27578967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934584A NO306928B1 (no) 1992-09-04 1993-12-13 Fremgangsmåte for fremstilling av steroidholdige granuler, samt granuler og tablett

Country Status (15)

Country Link
US (2) US5395627A (no)
EP (1) EP0657161B1 (no)
JP (1) JP3720385B2 (no)
CN (1) CN1050043C (no)
AT (1) ATE173918T1 (no)
AU (1) AU672447B2 (no)
CA (1) CA2111320A1 (no)
DE (1) DE69322396T2 (no)
DK (1) DK0657161T3 (no)
ES (1) ES2125300T3 (no)
FI (1) FI111221B (no)
GR (1) GR3029273T3 (no)
NO (1) NO306928B1 (no)
NZ (1) NZ250443A (no)
ZA (1) ZA939337B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976570A (en) * 1993-12-21 1999-11-02 Applied Analytical Industries, Inc. Method for preparing low dose pharmaceutical products
US6077533A (en) * 1994-05-25 2000-06-20 Purdue Pharma L.P. Powder-layered oral dosage forms
IL113816A (en) † 1994-06-08 1998-12-06 Akzo Nobel Nv Pharmaceutical preparations containing desogestral, their preparation and use
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
RU2159618C2 (ru) * 1995-06-22 2000-11-27 Акцо Нобель Н.В. Прессованные таблетки дезогестрела, изготовленные способом сухого гранулирования
WO1997004752A1 (en) * 1995-07-26 1997-02-13 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions of conjugated estrogens and methods for their use
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
GB9613470D0 (en) * 1996-06-27 1996-08-28 Ciba Geigy Ag Small solid oral dosage form
DE19652196A1 (de) * 1996-12-16 1998-06-18 Jenapharm Gmbh Homogene steroidhaltige Präformulierungen zur Herstellung niedrigdosierter fester und halbfester pharmazeutischer Zubereitungen
DK0927556T3 (da) * 1997-09-23 2000-11-20 Akzo Nobel Nv Coatede dosisenheder
ES2204613T3 (es) * 1999-04-06 2004-05-01 Akzo Nobel N.V. Androgenos 7-alfa alquilo oralmente activos.
DK1361881T3 (da) * 2000-12-14 2006-02-20 Ortho Mcneil Pharm Inc Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
US7303763B2 (en) * 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
US6630166B1 (en) 2001-02-12 2003-10-07 Watson Pharmaceuticals, Inc. Compositions for conjugated estrogens and associated methods
ES2199202T3 (es) * 2001-07-11 2004-02-16 Apr Applied Pharma Research S.A. Granulados que contienen sustancias liposolubles y un procedimiento para su preparacion.
TW200403075A (en) * 2002-05-29 2004-03-01 Akzo Nobel Nv Progestagenic dosage units
JP4756153B2 (ja) * 2004-08-27 2011-08-24 富士製薬工業株式会社 低成分含量の錠剤の製造方法
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US20070248665A1 (en) * 2006-04-24 2007-10-25 Sherman Bernard C Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
ES2903149T3 (es) * 2012-05-14 2022-03-31 Shionogi & Co Preparación que contiene derivado de 7-carbamoilmorfinano 6,7-insaturado
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
CN103271927A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进口服避孕药含量均匀性三级稀释法的工艺
CN103271928A (zh) * 2013-05-31 2013-09-04 南通联亚药业有限公司 一种改进去氧孕烯稳定性的处方工艺

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180560A (en) * 1976-10-26 1979-12-25 Syntex Corporation Inert core implant pellet
JPS59155309A (ja) * 1983-02-22 1984-09-04 Teijin Ltd 活性型ビタミンｄ↓３類組成物
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
EP0300523B1 (en) * 1987-07-06 1991-08-14 Akzo N.V. Pharmaceutical dosage unit for the prevention or treatment of climacteric complaints
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
US5035897A (en) * 1989-09-05 1991-07-30 Alza Corporation Dosage form for delivering soluble or insoluble drugs
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
IE71202B1 (en) * 1990-12-17 1997-02-12 Akzo Nv Progestagen-only contraceptive
US5200194A (en) * 1991-12-18 1993-04-06 Alza Corporation Oral osmotic device
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.

Also Published As

Publication number Publication date
US5527543A (en) 1996-06-18
EP0657161A1 (en) 1995-06-14
EP0657161B1 (en) 1998-12-02
NO306928B1 (no) 2000-01-17
CA2111320A1 (en) 1995-06-14
AU672447B2 (en) 1996-10-03
FI935584A (fi) 1995-06-14
JPH07196513A (ja) 1995-08-01
DE69322396T2 (de) 1999-07-29
JP3720385B2 (ja) 2005-11-24
DK0657161T3 (da) 1999-08-16
FI111221B (fi) 2003-06-30
DE69322396D1 (de) 1999-01-14
CN1050043C (zh) 2000-03-08
NO934584D0 (no) 1993-12-13
GR3029273T3 (en) 1999-05-28
NZ250443A (en) 1995-07-26
AU5239193A (en) 1995-07-13
ZA939337B (en) 1994-10-13
US5395627A (en) 1995-03-07
ATE173918T1 (de) 1998-12-15
FI935584A0 (fi) 1993-12-13
ES2125300T3 (es) 1999-03-01
CN1104487A (zh) 1995-07-05

Similar Documents

Publication Publication Date Title
NO934584D0 (no) Farmasoeytisk granulat
AU645709B2 (en) New 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
DE59403717D1 (de) Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AU2125192A (en) New naphthylethlylureas and naphthylethylthioureas, process for the preparation thereof, and pharmaceutical compositions containing them
HUT54705A (en) Process for producing 11 beta-aryl-4-estrenes and pharmaceutical compositions comprising same
FI894899A0 (fi) Menetelmä dispergoituvan kiinteän lääkeainekoostumuksen valmistamiseksi
GR3023311T3 (en) 17B-(3-Furyl) and 17B-(4-pyridazinyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
EP0159777A1 (en) Stabilized 4-carbamoyl-imidazolium-5-olate
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
ATE343585T1 (de) Steroide, ihre herstellung , pharmazeutische zusammensetzungen mit ihnen und verwendungen dieser verbindungen
EP0401894B1 (en) Freeze-dried, powdery cyclophosphamide composition, as well as process for its preparation
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
KR950016749A (ko) 약제용 과립 및 그 제조 방법
ATE30712T1 (de) 4-hydroxy-alpha-aethyl-benzhydrole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
IL87197A0 (en) Leukotriene antagonists,precursors of same,processes for the preparation thereof and pharmaceutical compositions containing same
Cunico et al. A Phenylcarbene Transfer System
TH14841EX (th) แกรนูลยา
JPS5626832A (en) Preparation of cyclopentenolone
TH13833EX (th) สารประกอบ
JPS57142967A (en) N-(acylthioalkanoyloxy)succinimide and its use
JPS57183778A (en) S-(3-phthalidyl)-l-cysteine and its preparation
JPS54125651A (en) Monocyclic beta-lactam derivative and its preparation
IT1255696B (it) Composto con attivita' vasodilatatrice procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
JPH04178303A (ja) 安定な農薬組成物

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP & DOHME BV, NL

MK1K Patent expired